Multiple sclerosisIn multiple sclerosis, the protective coating on nerve fibers (myelin) is damaged and may eventually be destroyed. Depending on where the nerve damage occurs, MS can affect vision, sensation, coordination, movement, and bladder and bowel control.Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system).In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause permanent damage or deterioration of the nerves. Myelin damage and the nervous systemIn multiple sclerosis, the protective coating on nerve fibers (myelin) in the central nervous system becomes detached and eventually destroyed. This creates a lesion that may cause numbness, pain or tingling in parts of the body.Multiple sclerosis signs and symptoms may differ greatly from person to person and over the course of the disease depending on the location of affected nerve fibers.

1. How Is Ms Diagnosed From Mri
2. How Is Ms Diagnosed Igg Index Markers
3. Symptoms Of Multiple Sclerosis In Women

CausesThe cause of multiple sclerosis is unknown. It's considered an autoimmune disease in which the body's immune system attacks its own tissues. In the case of MS, this immune system malfunction destroys the fatty substance that coats and protects nerve fibers in the brain and spinal cord (myelin).Myelin can be compared to the insulation coating on electrical wires. When the protective myelin is damaged and nerve fiber is exposed, the messages that travel along that nerve may be slowed or blocked.

The nerve may also become damaged itself.It isn't clear why MS develops in some people and not others. A combination of genetics and environmental factors appears to be responsible. Risk factorsThese factors may increase your risk of developing multiple sclerosis:. Age. MS can occur at any age, but usually affects people somewhere between the ages of 16 and 55. Sex. Women are more than two to three times as likely as men are to have relapsing-remitting MS.

Family history. If one of your parents or siblings has had MS, you are at higher risk of developing the disease. Certain infections.

A variety of viruses have been linked to MS, including Epstein-Barr, the virus that causes infectious mononucleosis. Race. White people, particularly those of Northern European descent, are at highest risk of developing MS. People of Asian, African or Native American descent have the lowest risk. Climate. MS is far more common in countries with temperate climates, including Canada, the northern United States, New Zealand, southeastern Australia and Europe.

Vitamin D. Having low levels of vitamin D and low exposure to sunlight is associated with a greater risk of MS.

Certain autoimmune diseases. You have a slightly higher risk of developing MS if you have thyroid disease, type 1 diabetes or inflammatory bowel disease. Smoking.

Smokers who experience an initial event of symptoms that may signal MS are more likely than nonsmokers to develop a second event that confirms relapsing-remitting MS.ComplicationsPeople with multiple sclerosis may also develop:. Muscle stiffness or spasms. Paralysis, typically in the legs. Problems with bladder, bowel or sexual function.

Mental changes, such as forgetfulness or mood swings. Depression. Epilepsy. What is multiple sclerosis?

National Multiple Sclerosis Society. Accessed Dec. 14, 2018. Daroff RB, et al. Multiple sclerosis and other inflammatory demyelinating diseases of the central nervous system. In: Bradley's Neurology in Clinical Practice.

Philadelphia, Pa.: Elsevier Saunders; 2012. Accessed Dec. 14, 2018. Ferri FF. Multiple sclerosis.

In: Ferri's Clinical Advisor 2019. Philadelphia, Pa.: Elsevier; 2019.

Accessed Dec. 14, 2018. Olek MJ. Clinical presentation, course, and prognosis of multiple sclerosis in adults. Accessed Dec.

14, 2018. Wingerchuk DM (expert opinion). Mayo Clinic, Phoenix/Scottsdale, Ariz. 21, 2019. Ciccarelli O.

Multiple sclerosis in 2018: New therapies and biomarkers. 2019;18:12. Keegan BM. Therapeutic decision making in a new drug era in multiple sclerosis. Seminars in Neurology.

2013;33:5. Goldman L, et al., eds. Multiple sclerosis and demyelinating conditions of the central nervous system.

In: Goldman-Cecil Medicine. Philadelphia, Pa.: Saunders Elsevier; 2016. Accessed Dec. 14, 2018. Lotze TE. Pathogenesis, clinical features, and diagnosis of pediatric multiple sclerosis.

Accessed Dec. 14, 2018. Kantarci OH, et al. Novel immunomodulatory approaches for the management of multiple sclerosis.

Clinical Pharmacology & Therapeutics. 2014;95:32. Olek MJ.

Disease-modifying treatment of relapsing-remitting multiple sclerosis in adults. Accessed Dec. 14, 2018. Olek MJ, et al.

Bus Simulator Indonesia (aka BUSSID) will let you experience what it likes being a bus driver in Indonesia in a fun and authentic way. BUSSID might not be the first one, but it's probably one of the only bus simulator games with the most features and the most authentic Indonesian environment. Below are some of Bus. Download game simulator bus versi indonesia.

Treatment of acute exacerbations of multiple sclerosis in adults. Accessed Dec. 14, 2018. Wingerchuk DM. Multiple sclerosis: Current and emerging disease-modifying therapies and treatment strategies. Mayo Clinic Proceedings. 2014;89:225.

Pizzorno JE, et al. Multiple sclerosis. In: Textbook of Natural Medicine. Louis, Mo.: Churchill Livingstone Elsevier; 2013. Accessed Dec. 14, 2018.

Olek MJ, et al. Evaluation and diagnosis of multiple sclerosis in adults. Accessed Dec.

14, 2018. Gaetani L, et al.

2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes. Journal of Neurology. Olek MJ, et al. Pathogenesis and epidemiology of multiple sclerosis.Accessed Dec. 17, 2018. Olek MJ, et al. Symptom management of multiple sclerosis in adults.

Accessed Dec. 14, 2018. Yadav Y, et al. Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis. 20.

Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. March 27, 2018. National MS Society. Network of Pediatric MS Centers. Accessed Dec.

Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. CD8+ T cells cause disability and axon loss in a mouse model of multiple sclerosis. 2010;5:e12478.

How Is Ms Diagnosed From Mri

FDA approves new drug to treat multiple sclerosis. Food & Drug Administration. Accessed Feb.

How Is Ms Diagnosed Igg Index Markers

1, 2019. Keegan BM (expert opinion).

Mayo Clinic, Rochester, Minn. 15, 2019. FDA approves new oral drug to treat multiple sclerosis. Food and Drug Administration. Accessed March 29, 2019. Kappos L, et al.

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): A double-blind, randomised, phase 3 study. 2018;391:1263.

Symptoms Of Multiple Sclerosis In Women

Marin Collazo IV (expert opinion). Mayo Clinic, Rochester, Minn. April 2, 2019.